Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

This publication has 24 references indexed in Scilit:

• Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
  Archives of internal medicine (1960), 1988
• TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM
  American Journal of Epidemiology, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• The removal of cholesterol from aortic smooth muscle cells in culture and landschutz ascites cells by fractions of human high-density apolipoprotein
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
• PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
  The Lancet, 1975
• Five-year myocardial infarction incidence—II. Association of single variables to age and birthplace
  Journal of Chronic Diseases, 1973
• a-Cholesterol percentages in coronary patients with and without increased total serum cholesterol levels and in healthy controls
  Journal of Atherosclerosis Research, 1962
• SERUM CHOLESTEROL, ELECTROPHORETIC LIPID PATTERN, DIET AND CORONARY ARTERY DISEASE: A STUDY IN CORONARY PATIENTS AND IN HEALTHY MEN OF DIFFERENT ORIGIN AND OCCUPATIONS IN ISRAEL
  Annals of Internal Medicine, 1958
• Protein-lipid relationships in human plasma
  The American Journal of Medicine, 1951